The wearable diagnostic biosensor can detect three interconnected compounds - cortisol, glucose and interleukin-6 - in sweat for up to a week without loss of signal integrity.
"Type 2 diabetes affects so many people. If you have to manage and regulate this chronic problem, these markers are the levers that will help you do that," said Shalini Prasad, a professor at The University of Texas at Dallas in the US.
Also Read
"If a person has chronic stress, their cortisol levels increase, and their resulting insulin resistance will gradually drive their glucose levels out of the normal range," said Prasad.
"At that point, one could become pre-diabetic, which can progress to type 2 diabetes, and so on. If that happens, your body is in a state of inflammation, and this inflammatory marker, interleukin-6, will indicate that your organs are starting to be affected," she said.
The team showed that the biomarker measurements are reliable even with a tiny amount of sweat - just one to three microliters, much less than the 25 to 50 previously believed necessary.
"We wanted to make a product more useful than something disposable after a single use," Prasad said.
"It also has to require only your ambient sweat, not a huge amount," she said.
"And it's not enough to detect just one thing. Measuring multiple molecules in a combinatorial manner and tracking them over time allows us to tell a story about your health," she added.
Prasad envisions that the wearable devices will contain a small transceiver to send data to an application installed on a cellphone.
"With the app we're creating, you'll simply push a button to request information from the device," Prasad said.
"If you measure levels every hour on the hour for a full week, that provides 168 hours' worth of data on your health as it changes," she said.
Prasad has emphasised "frugal innovation" throughout the development process, making sure the end product is accessible for as many people as possible.
"We made sure we used processes that will allow for mass production without adding cost," Prasad said.
"Our cost of manufacturing will be comparable to what it currently takes to make single-use glucose test strips - as little as 10 to 15 cents," she said.
The study was published in the journal Scientific Reports.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)